| New Chemotherapeutic Strategies against Malaria, Leishmaniasis, and Trypanomiases. | |
| | |
MedLine Citation:
|
PMID: 23210775 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Due to the persistent lack of suitable vaccines, chemotherapy remains the only option for the treatment of patients infected by protozoan parasites. However, most available antiparasitic drugs have serious disadvantages, ranging from high cost and poor compliance to high toxicity and rapid induction of resistance. In recent decades basic research laboratories identified a considerable number of promising new molecules, but their development has not been pursued in depth by pharmaceutical firms because of poor prospects of economic return. The establishment of adequately funded public-private partnerships is currently reversing the trend. This review deals with new drugs against Plasmodium, Leishmania and Trypanosoma parasites, focusing on the molecules that are in the most advanced stage of development. The purpose of this article is to provide the reader with a panoramic view of the updated literature on the challenges and strategies of contemporary antiprotozoal drug research, paying the due attention to the already published reviews. |
| | |
Authors:
|
Mario Zucca; Sara Scutera; Dianella Savoia |
Related Documents
:
|
6389825 - Microbial kinetics of beta-lactam antibiotics against escherichia coli. 14977165 - Estimation of cmax and tmax in populations after single and multiple drug administrations. 4049475 - Radioimmunoassay for clonidine in human plasma and urine using a solid phase second ant... 2498945 - A fixed dose study of the plasma concentration and clinical effects of thioridazine and... 3530585 - Renal safety of two analgesics used over the counter: ibuprofen and aspirin. 11243395 - Molecular signals in anti-apoptotic survival pathways. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-12-03 |
Journal Detail:
|
Title: Current medicinal chemistry Volume: - ISSN: 1875-533X ISO Abbreviation: Curr. Med. Chem. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9440157 Medline TA: Curr Med Chem Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Dept. of Clinical and Biological Sciences, at S. Luigi Gonzaga Hospital, University of Torino, Regione Gonzole 10, 10043 Orbassano (To), Italy. dianella.savoia@unito.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Kinase Ck2 inhibition: AN update.
Next Document: New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumours by Plant Polyph...